ATE520419T1 - Verfahren zur herstellung von polymer-konjugaten von doxorubicin mit ph-kontrollierter freisetzung des arzneimittels - Google Patents

Verfahren zur herstellung von polymer-konjugaten von doxorubicin mit ph-kontrollierter freisetzung des arzneimittels

Info

Publication number
ATE520419T1
ATE520419T1 AT06775676T AT06775676T ATE520419T1 AT E520419 T1 ATE520419 T1 AT E520419T1 AT 06775676 T AT06775676 T AT 06775676T AT 06775676 T AT06775676 T AT 06775676T AT E520419 T1 ATE520419 T1 AT E520419T1
Authority
AT
Austria
Prior art keywords
doxorubicin
controlled release
medicinal product
polymer conjugates
producing polymer
Prior art date
Application number
AT06775676T
Other languages
English (en)
Inventor
Tomas Etrych
Petr Chytil
Martin Studenovsky
Michal Pechar
Karel Ulbrich
Blanka Rihova
Original Assignee
Zentiva Ks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva Ks filed Critical Zentiva Ks
Application granted granted Critical
Publication of ATE520419T1 publication Critical patent/ATE520419T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT06775676T 2005-09-05 2006-09-05 Verfahren zur herstellung von polymer-konjugaten von doxorubicin mit ph-kontrollierter freisetzung des arzneimittels ATE520419T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20050558A CZ297827B6 (cs) 2005-09-05 2005-09-05 Zpusob prípravy polymerních konjugátu doxorubicinu s pH-rízeným uvolnováním léciva
PCT/CZ2006/000056 WO2007028347A2 (en) 2005-09-05 2006-09-05 Method for the preparation of polymeric conjugates of doxorubicin with ph- controlled release of the drug

Publications (1)

Publication Number Publication Date
ATE520419T1 true ATE520419T1 (de) 2011-09-15

Family

ID=37667174

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06775676T ATE520419T1 (de) 2005-09-05 2006-09-05 Verfahren zur herstellung von polymer-konjugaten von doxorubicin mit ph-kontrollierter freisetzung des arzneimittels

Country Status (7)

Country Link
US (1) US20080318879A1 (de)
EP (1) EP1922087B1 (de)
AT (1) ATE520419T1 (de)
CZ (1) CZ297827B6 (de)
EA (1) EA015091B1 (de)
UA (1) UA94594C2 (de)
WO (1) WO2007028347A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ299053B6 (cs) * 2006-08-09 2008-04-09 Zentiva, A. S. Polymerní konjugáty doxorubicinu s pH-rízeným uvolnováním léciva a zpusob jejich prípravy
CN101501492B (zh) * 2006-08-09 2013-05-15 住友电木株式会社 糖链捕获物及其用途
CZ298945B6 (cs) * 2006-09-18 2008-03-19 Zentiva, A. S. Polymerní lécivo a zpusob jeho výroby
US20100316697A1 (en) * 2007-05-10 2010-12-16 Clear Direction Ltd. Methods and compositions for drug targeting
US8524784B2 (en) * 2009-04-30 2013-09-03 Intezyne Technologies, Incorporated Polymer micelles containing anthracylines for the treatment of cancer
WO2010127271A1 (en) 2009-04-30 2010-11-04 Intezyne Technologies, Incorporated Polymer micelles containing anthracylines for the treatment of cancer
CN103936945B (zh) * 2013-01-23 2017-02-08 中国科学院化学研究所 一类高效抗肿瘤靶向药物载体及其制备方法
CN105727309B (zh) * 2016-03-31 2019-04-30 中国药科大学 双敏感两亲性多糖-阿霉素偶联物及其药学组合物的制备和应用
CN105963706B (zh) * 2016-04-15 2019-03-15 四川大学 一种支化hpma共聚物-dox偶联物及其制备方法和应用
CN105903031A (zh) * 2016-05-05 2016-08-31 上海交通大学 肿瘤微环境敏感的药物控释纳米体系的制备方法及其应用
GB2551979A (en) * 2016-06-30 2018-01-10 Rs Arastirma Egitim Danismanlik Llac Sanayi Ticaret Ltd Cleavable polymer drug conjugates

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060518A (en) * 1996-08-16 2000-05-09 Supratek Pharma Inc. Polymer compositions for chemotherapy and methods of treatment using the same
DE19636889A1 (de) * 1996-09-11 1998-03-12 Felix Dr Kratz Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel
CZ293787B6 (cs) * 2001-12-20 2004-07-14 Zentiva, A.S. pH senzitivní polymerní konjugáty antracyklinového kancerostatika pro cílenou terapii
AU2002953073A0 (en) * 2002-11-21 2003-01-16 Access Pharmaceuticals Australia Pty Limited Amplification of biotin-mediated targeting
CZ293886B6 (cs) * 2002-12-20 2004-08-18 Zentivaźáa@S pH senzitivní polymerní konjugáty antracyklinového kancerostatika pro cílenou terapii
CZ294996B6 (cs) * 2003-07-16 2005-04-13 Ústav Makromolekulární Chemie Av Čr Reaktivní polymery a kopolymery na bázi N-(2-hydroxypropyl)methakrylamidu, způsob jejich přípravy a jejich použití pro syntézu polymerních léčiv, pro modifikaci biologicky aktivních proteinů a přípravu systémů pro dopravu genů
WO2005117932A1 (en) * 2004-06-04 2005-12-15 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Bisubstrate inhibitors of protein tyrosine kinases as therapeutic agents
GB0413613D0 (en) * 2004-06-17 2004-07-21 Univ London Small molecule carriers
US7968085B2 (en) * 2004-07-05 2011-06-28 Ascendis Pharma A/S Hydrogel formulations

Also Published As

Publication number Publication date
UA94594C2 (ru) 2011-05-25
US20080318879A1 (en) 2008-12-25
EA015091B1 (ru) 2011-06-30
CZ2005558A3 (cs) 2007-04-04
CZ297827B6 (cs) 2007-04-04
EA200800756A1 (ru) 2008-06-30
EP1922087A2 (de) 2008-05-21
WO2007028347A2 (en) 2007-03-15
WO2007028347A3 (en) 2007-05-10
EP1922087B1 (de) 2011-08-17

Similar Documents

Publication Publication Date Title
ATE520419T1 (de) Verfahren zur herstellung von polymer-konjugaten von doxorubicin mit ph-kontrollierter freisetzung des arzneimittels
Broyer et al. Designed amino acid ATRP initiators for the synthesis of biohybrid materials
Bauri et al. Amino acid-derived stimuli-responsive polymers and their applications
Wilke et al. A direct biocombinatorial strategy toward next generation, mussel-glue inspired saltwater adhesives
Robin et al. Conjugation-induced fluorescent labeling of proteins and polymers using dithiomaleimides
Ten Cate et al. Sequence-defined polypeptide− polymer conjugates utilizing reversible addition fragmentation transfer radical polymerization
Fehrentz et al. Solid phase synthesis of C-terminal peptide aldehydes
ATE455806T1 (de) (meth)acrylsäureester ungesättigter aminoalkohole und deren herstellung
CA2420590A1 (en) Active agent delivery systems and methods for protecting and administering active agents
WO2007140192A3 (en) Acid functionalized gradient block copolymers
BRPI0413323A (pt) processo para a preparação de vacinas conjugadas de polissacarìdeo-proteìna
ATE509940T1 (de) Massiv parallele synthese biopolymerer arrays
Trimaille et al. SG1-Functionalized Peptides as Precursors for Polymer− Peptide Conjugates: A Straightforward Approach
HRP20060449T3 (en) Process for the preparation of (1s)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane, acid additon salts thereof and its use for the synthesis of ivabradine and for its pharmaceutically acceptable acid addition salts
TW200602358A (en) Production of polymers
WO2007022193A3 (en) Process for the preparation of copolymer-1
WO2005039641A3 (en) Biomacromolecule polymer conjugates
Imamura et al. Synthesis of zwitterionic polymers containing a tertiary sulfonium group for protein stabilization
JP6468562B2 (ja) プロテアソーム阻害性化合物
HUP0500541A2 (hu) Rákellenes antraciklin hatóanyag célterápiára alkalmas pH-érzékeny polimer konjugátjai
Jimenez et al. Fundamental Insights into Free-Radical Polymerization in the Presence of Catechols and Catechol-Functionalized Monomers
DE602007012111D1 (de) Polymerkonjugate von doxorubicin mit ph-regulierter freisetzung des arzneimittels und herstellungsverfahren
EA200600259A1 (ru) Реакционноспособные полимеры и сополимеры на основе n-(2-гидроксипропил)метакриламида, способ их получения и их применение для синтеза полимерных лекарственных средств, для модификации биологически активных белков и получения систем доставки генов
DE60317066D1 (de) Verfahren zur herstellung von blockcopolymeren
Chen et al. Implication of side reactions in iterative biopolymer synthesis: The case of membrane enhanced peptide synthesis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties